Clinical Trial Update: PN-943 in Adults With Moderate to Severe Active Ulcerative Colitis (UC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for PN-943 in adults with moderate to severe active ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• PN-943

Snippet

Sponsor: Protagonist Therapeutics, Inc. | Conditions: Ulcerative Colitis Chronic Moderate, Ulcerative Colitis Chronic Severe | Phase 2 | Status: COMPLETED